![Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile](/docs/US/2023-10-10/US11780852B2/abs.jpg.600x600.jpg)
- Patent Title: Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
-
Application No.: US17248832Application Date: 2021-02-10
-
Publication No.: US11780852B2Publication Date: 2023-10-10
- Inventor: Ryan Hudson , Jennifer Kozak , Dante D. Podesto , Xiaojun Huang , Venkat R. Thalladi
- Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee: Theravance Biopharma R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agency: SHEPPARD MULLIN RICHTER & HAMPTON LLP
- The original application number of the division: US15631220 2017.06.23
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; C07D471/04 ; C07D519/00 ; A61K31/46 ; A61K45/06
![Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile](/abs-image/US/2023/10/10/US11780852B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are methods for treating Crohn's disease using a compound of the formula:
or a pharmaceutically-acceptable salt thereof.
or a pharmaceutically-acceptable salt thereof.
Public/Granted literature
- US20210179637A1 NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS Public/Granted day:2021-06-17
Information query
IPC分类:
